Multicentre randomised study of computerised anticoagulant dosage

被引:174
作者
Poller, L
Shiach, CR
MacCallum, PK
Johansen, AM
Münster, AM
Magalhaes, A
Jespersen, J
机构
[1] Univ Manchester, Dept Pathol Sci, ECAA Cent Facil, Manchester M13 9PT, Lancs, England
[2] Manchester Royal Infirm, Dept Haematol, Manchester M13 9WL, Lancs, England
[3] St Bartholomews & Royal London Sch Med, MRC, Epidemiol & Med Care Unit, London, England
[4] Aker Sykehus, Dept Med A, Oslo, Norway
[5] Cent Sygehuset, Dept Clin Biochem, Esbjerg, Denmark
[6] Ctr Hosp VN de Gaia, Serv Imunohemoterapia, Vila Nova De Gaia, Portugal
关键词
D O I
10.1016/S0140-6736(98)04147-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The demand for anticoagulant treatment is increasing. We compared the benefits of computer generated anticoagulaant dosing with traditional dosing decided by experienced medical staff in achieving target international normalised ratios (INRs). Methods In five European centres we randomly assigned 285 patients in the stabilisation period and stabilised patients to the computer-generated-dose group (n=137) or traditional-dose group (n=148). Centres had a specialist interest in oral anticoagulation but no previous experience with computer-generated dosing. The computer program calculated doses and times to next visit. Our main endpoint was time spent in target INR range (Rosendaal method). Findings For all patients combined, computer-generated dosing was significantly beneficial overall in achieving target INR (p=0.004). The mean time within target INR range for all patients and ail ranges was 63.3% (SD 28.0) of days in the computer-generated-dose group compared with 53.2% (27.7) in the traditional-dose group. For the stabilisation patients alone, computer-generated doses led to a non-significant benefit in all INR ranges (p=0.06), whereas in the stable patients the benefit was significant (p=0.02). Interpretation The computer program gave better INR control than the experienced medical staff and at least similar standards to the specialised centres should be generally available. Clinical outcome and cost effectiveness remain to be assessed.
引用
收藏
页码:1505 / 1509
页数:5
相关论文
共 11 条
[1]  
AGENO W, 1997, THROMB HAEMOSTASIS, V77, P701
[2]   Decentralised anticoagulant care [J].
Baglin, T .
JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (02) :89-90
[3]  
COLVIN BT, 1990, J CLIN PATHOL, V43, P177
[4]  
GALVIN M, 1994, P DAWN AC US GROUP M, P1
[5]  
HIRSH J, 1995, CHEST S, V108, P231
[6]  
LOELIGER EA, 1984, THROMB HAEMOSTASIS, V54, P514
[7]   PROSPECTIVE COMPARATIVE-STUDY OF COMPUTER-PROGRAMS USED FOR MANAGEMENT OF WARFARIN [J].
POLLER, L ;
WRIGHT, D ;
ROWLANDS, M .
JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (04) :299-303
[8]  
ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236
[9]   COMPUTER CONTROL OF ANTICOAGULANT DOSE FOR THERAPEUTIC MANAGEMENT [J].
RYAN, PJ ;
GILBERT, M ;
ROSE, PE .
BRITISH MEDICAL JOURNAL, 1989, 299 (6709) :1207-1209
[10]  
SMITH SGW, 1989, BRIT MED J, V299, P1529